Stock Scorecard
Stock Summary for Durect Corp (DRRX) - $1.94 as of 8/29/2025 3:19:04 PM EST
Total Score
5 out of 30
Safety Score
14 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DRRX
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DRRX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DRRX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DRRX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for DRRX (14 out of 100)
Stock Price Rating (Max of 10) | 2 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 2 |
Analyst Strong Buy Ratings (Max of 5) | 0 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DRRX
Financial Details for DRRX
Company Overview |
|
---|---|
Ticker | DRRX |
Company Name | Durect Corp |
Country | USA |
Description | DURECT Corporation, a biopharmaceutical company, researches and develops drugs based on its epigenetic regulator and pharmaceutical programs. The company is headquartered in Cupertino, California. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 1.94 |
Price 4 Years Ago | 9.86 |
Last Day Price Updated | 8/29/2025 3:19:04 PM EST |
Last Day Volume | 208,657 |
Average Daily Volume | 2,139,311 |
52-Week High | 2.64 |
52-Week Low | 0.48 |
Last Price to 52 Week Low | 304.17% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 40.47 |
Sector PE | 60.89 |
5-Year Average PE | -2.68 |
Free Cash Flow Ratio | 9.24 |
Industry Free Cash Flow Ratio | 15.46 |
Sector Free Cash Flow Ratio | 30.76 |
Current Ratio Most Recent Quarter | 0.98 |
Total Cash Per Share | 0.21 |
Book Value Per Share Most Recent Quarter | 0.11 |
Price to Book Ratio | 17.30 |
Industry Price to Book Ratio | 28.68 |
Sector Price to Book Ratio | 26.74 |
Price to Sales Ratio Twelve Trailing Months | 36.36 |
Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
Analyst Buy Ratings | 1 |
Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
Total Shares Outstanding | 31,054,200 |
Market Capitalization | 60,245,148 |
Institutional Ownership | 23.58% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 1.17% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 69.87% |
Reported EPS 12 Trailing Months | -0.43 |
Reported EPS Past Year | -0.20 |
Reported EPS Prior Year | -0.57 |
Net Income Twelve Trailing Months | -3,478,000 |
Net Income Past Year | -8,324,000 |
Net Income Prior Year | -27,624,000 |
Quarterly Revenue Growth YOY | -30.80% |
5-Year Revenue Growth | -41.47% |
Operating Margin Twelve Trailing Months | -627.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 6,502,000 |
Total Cash Past Year | 11,011,000 |
Total Cash Prior Year | 28,400,000 |
Net Cash Position Most Recent Quarter | -3,964,000 |
Net Cash Position Past Year | -5,652,000 |
Long Term Debt Past Year | 16,663,000 |
Long Term Debt Prior Year | 21,170,000 |
Total Debt Most Recent Quarter | 10,466,000 |
Equity to Debt Ratio Past Year | 0.35 |
Equity to Debt Ratio Most Recent Quarter | 0.27 |
Total Stockholder Equity Past Year | 9,131,000 |
Total Stockholder Equity Prior Year | 14,783,000 |
Total Stockholder Equity Most Recent Quarter | 3,937,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -13,966,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.45 |
Free Cash Flow Past Year | -19,086,000 |
Free Cash Flow Prior Year | -34,466,000 |
Options |
|
Put/Call Ratio | 5.52 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.21 |
MACD Signal | 0.25 |
20-Day Bollinger Lower Band | -0.17 |
20-Day Bollinger Middle Band | 0.94 |
20-Day Bollinger Upper Band | 2.05 |
Beta | 0.84 |
RSI | 78.05 |
50-Day SMA | 0.94 |
150-Day SMA | 2.28 |
200-Day SMA | 3.43 |
System |
|
Modified | 8/29/2025 10:07:45 PM EST |